育龄期女性接种第三剂麻腮风疫苗前后风疹病毒特异性体液免疫应答及其相互关系
研究纳入109名有两次麻腮风疫苗接种记录的育龄期女性,检测第三剂接种前后风疹特异性中和抗体、ELISA IgG滴度和抗体亲和力及记忆B细胞频率。基线时4人(3.67%)风疹ELISA IgG滴度<10 IU/mL为血清阴性;接种后28天中和抗体几何平均滴度为243 NT50(CI 241, 245),IgG几何平均滴度为150 IU/mL(CI 148, 152),无血清阴性者。约三分之一受试者抗体滴度出现≥4倍显著提升(中和抗体31.8%,IgG 30.8%),高应答组各项免疫指标显著高于低应答组。
要点
- 109名有两次麻腮风疫苗接种史的育龄期女性中,基线4人(3.67%)风疹ELISA IgG<10 IU/mL,提示缺乏保护。
- 第三剂接种后28天中和抗体几何平均滴度243 NT50(CI 241, 245),IgG几何平均滴度150 IU/mL(CI 148, 152),无血清阴性者。
- 31.8%受试者中和抗体、30.8%受试者IgG滴度出现≥4倍显著提升,高应答组免疫指标显著高于低应答组。
核心结论
- 研究提示未知的固有生物学和免疫因素对风疹疫苗诱导的体液免疫应答的产生和维持具有重要意义。
研究设计与样本
- 从1117人队列中按风疹特异性抗体应答谱高、低两端选取109名有两次麻腮风疫苗接种记录的育龄期女性(中位年龄34.5岁),检测第三剂MMR-II接种前后风疹特异性体液免疫及抗原特异性记忆B细胞频率。
主要发现
- 基线时4人(占全部受试者3.67%,占低应答组7.14%)风疹特异性ELISA IgG滴度<10 IU/mL,为血清阴性。
- 第三剂接种后1个月队列中和抗体几何平均滴度峰值243 NT50(CI 241, 245),第28天IgG几何平均滴度峰值150 IU/mL(CI 148, 152),无血清阴性个体。
- 全部受试者中31.8%(中和抗体)和30.8%(IgG滴度)在接种后1个月出现≥4倍抗体滴度显著提升。
- 高应答组抗体滴度及其他检测的免疫应答变量显著高于低应答组。
- 风疹特异性记忆B细胞频率与抗体滴度呈适度相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In the U.S., measles, mumps, and rubella vaccination is recommended as two vaccine doses. A third dose of measles-mumps-rubella (MMR) vaccine is being administered in certain situations (e.g., identified seronegativity and during outbreaks). We studied rubella-specific humoral immunity (neutralizing antibody, enzyme-linked immunosorbent assay/ELISA IgG titer and antibody avidity) and the frequencies of antigen-specific memory B cells before and after a third dose of MMR-II in 109 female participants of childbearing age (median age, 34.5 years old) from Olmsted County, MN, with two documented prior MMR vaccine doses. The participants were selected from a cohort of 1117 individuals if they represented the high and the low ends of the rubella-specific antibody response spectrum. Of the 109 participants, we identified four individuals (3.67% of all study participants; 7.14% of the low-responder group) that were seronegative at Baseline (rubella-specific ELISA IgG titers <10 IU/mL), suggesting a lack of protection against rubella before receipt of a third MMR vaccine dose. The peak geometric mean neutralizing antibody titer one month following the third dose of MMR vaccine for the cohort was 243 NT50 (CI; 241, 245), which is expected for a cohort with two doses of MMR, and the peak geometric mean IgG titer was 150 IU/mL (CI; 148, 152) with no seronegative individuals at Day 28. One-third of all subjects (31.8% for the neutralizing antibody; 30.8% for the IgG titer) experienced a significant boost (≥4-fold) of antibody titers one month following vaccination. Antibody titers and other tested immune-response variables were significantly higher in the high-responder group compared to the low-responder group. The frequencies of rubella-specific memory B cells were modestly associated with the antibody titers. Our study suggests the importance of yet unknown inherent biologic and immune factors for the generation and maintenance of rubella-vaccine-induced humoral immune responses.
引用
- Haralambieva IH, Ovsyannikova IG, Kennedy RB, et al. Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age. Vaccine. 2019. PMID: 31732325. doi:10.1016/j.vaccine.2019.11.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。